Abstract
The population of one or more partially folded states has been proposed as a critical initial step in amyloid formation for several proteins. Here we use equilibrium denaturation measured by 1H-15N NMR to determine the conformational properties of an amyloidogenic intermediate of human β2-microglobulin (β2m) formed at low pH. The data show that this amyloid precursor is a noncooperatively stabilized ensemble that retains stable structure in five of the seven β-strands that comprise the native fold. The amyloid precursors of β2m and transthyretin have similar properties despite having structurally unrelated native folds. The data offer a rationale as to why these proteins are both amyloidogenic at low pH and suggest that amyloidosis of these and other proteins may involve ordered assembly from a precursor with similar conformational features.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Sunde, M. & Blake, C. Adv. Prot. Chem. 50, 123–159 (1997).
Sunde, M. et al. J. Mol. Biol. 273, 729–739 (1997).
Rochet, J. & Lansbury, P.T. Jr Curr. Opin. Struct. Biol. 10, 60–68 (2000).
Liu, K., Cho, H.S., Lashuel, H.A., Kelly, J.W. & Wemmer, D.E. Nature Struct. Biol. 7, 754–757 (2000).
Bjorkman, P.J. et al. Nature 329, 506–512 (1987).
Campistol, J.M. et al. Kidney Int. 46, 577 (1994).
Gejyo, F. et al. Biochem. Biophys. Res. Commun. 129, 701–706 (1985).
Bellotti, V. et al. Eur. J. Biochem. 258, 61–67 (1998).
McParland, V.J. et al. Biochemistry 39, 8735–8746 (2000).
Esposito, G. et al. Protein Sci. 9, 831–845 (2000).
Morgan, C.J., Gelfand, M., Atreya, C. & Miranker, A.D. J. Mol. Biol. 309, 339–345 (2001).
Smith, D. & Radford, S.E. Protein Sci. 10, 1775–1784 (2001).
Yamaguchi, I., Hasegawa, K., Takahasji, N., Gejyo, F. & Naiki, H. Biochemistry 40, 8499–8507 (2001).
Kad, N.M., Thomson, N.H., Smith, D.P., Smith, D.A. & Radford, S.E. J. Mol. Biol. 313, 559–571 (2001).
Chiti, F. et al. J. Biol. Chem. 276, 46714–46721 (2001).
Gorevic, P.D. et al. Proc. Natl. Acad. Sci. U S A 83, 7908–7912 (1986).
Naiki, H., Hashimoto, N., Suzuki, S., Kimura, H., Nakakuki, K. & Gejyo, F. Amyloid 4, 223–232 (1997).
Dyson, H.J. & Wright, P.E. Nature Struct. Biol. 5 Suppl, 499–503 (1998).
Dobson, C.M. & Hore, P.J. Nature Struct. Biol. 5 Suppl, 504–507 (1998).
Chamberlain, A.K. & Marqusee, S. Adv. Protein Chem. 53, 283–328 (2000).
Redfield, C., Schulman, B.A., Mihollen, M.A., Kim, P.S. & Dobson, C.M. Nature Struct. Biol. 280, 167–174 (1999).
Schulman, B.A., Kim, P.S., Dobson, C.M. & Redfield, C. Nature Struct. Biol. 4, 630–634 (1997).
Clarke, J., Cota, E., Fowler, S.B. & Hamill, S.J. Structure 7, 1145–1153 (1999).
Kozhukh, G.V. et al. J. Biol. Chem. 277, 1310–1315 (2002).
Lansbury, P.T. Proc. Natl. Acad. Sci. USA 96, 3342–3344 (1999).
Hoshino, M. et al. Nature Struct. Biol. 9, 332–336 (2002), advanced online publication, 22 April 2002 (10.1038/nsb792).
Philo, J.S. Anal. Biochem. 279, 151–163 (2000).
Delaglio, F. et al. J. Biomol. NMR 6, 277–293 (1995).
Khan, A.R., Baker, B.M., Ghosh, P., Biddison, W.E. & Wiley, D.C. J. Immunol. 164, 6398–6405 (2000).
Kabsch, W. & Sander, C. Biopolymers 22, 2577–2637 (1983).
Kraulis, P.J. J. Appl. Crystallogr. 24, 946–950 (1991).
Merritt, E.A. & Murphy, M.E.P. Acta Crystallogr. D 50, 869–873 (1994).
Acknowledgements
We thank A. Baron for performing the ultracentrifugation experiments, A. Ashcroft for mass spectrometry and B. Jakobsen for providing the expression construct for β2m. We are very grateful to M. Sunde, C. Redfield, C. Dobson, J. Kelly, D. Westhead, F. Chiti, A. Berry and members of the S.E.R. group for helpful discussions. We acknowledge with thanks the financial support from The University of Leeds, The Wellcome Trust, British Biotech Pharmaceuticals Ltd. and the BBSRC. V.J.M. is supported by the Wellcome Trust. S.E.R. is a BBSRC Professorial Fellow. The paper is a contribution from the Astbury Centre for Structural Molecular Biology, which is part of the North of England Structural Biology Centre and is supported by the BBSRC.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
McParland, V., Kalverda, A., Homans, S. et al. Structural properties of an amyloid precursor of β2-microglobulin. Nat Struct Mol Biol 9, 326–331 (2002). https://doi.org/10.1038/nsb791
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nsb791
This article is cited by
-
Dynamics of free versus complexed β2-microglobulin and the evolution of interfaces in MHC class I molecules
Immunogenetics (2013)
-
β2-microglobulin forms three-dimensional domain-swapped amyloid fibrils with disulfide linkages
Nature Structural & Molecular Biology (2011)
-
A regulatable switch mediates self-association in an immunoglobulin fold
Nature Structural & Molecular Biology (2008)
-
Specific glycosaminoglycans promote unseeded amyloid formation from β2-microglobulin under physiological conditions
Kidney International (2007)
-
Amyloid formation under physiological conditions proceeds via a native-like folding intermediate
Nature Structural & Molecular Biology (2006)